Literature DB >> 8087248

The potential role of perfluorochemicals (PFCs) in diagnostic imaging.

R F Mattrey1.   

Abstract

Although perfluorochemicals (PFCs) are known for their ability to carry oxygen, they are the most versatile and only universal contrast agents with important applications using x-ray, ultrasound, or magnetic resonance (MR). The characteristics that make them unique diagnostic agents are lack of hydrogen atoms, immiscibility with water, low surface tension, compressibility, and long intravascular persistence when emulsified and given i.v. When made radiopaque, they are visible with x-ray computed tomography (CT) and standard radiography. Because the neat liquid is inert it can be ingested, instilled in the lung, or introduced into any hollow organ to image the lumen without untoward effects. The long intravascular persistence allows the imaging of blood vessels and vascularized tissues. Small or deep vessels become visible on Color Doppler Imaging and angiographic images of any vascular tree including the coronaries can be rendered from the serial CT images. As PFCs accumulate within RE cells, specific liver and spleen enhancement is achieved allowing the detection of small tumors within these organs. When injected interstitially, the particles find their way to the draining lymphnodes providing detail of the internal architecture to detect the presence or absence of tumor involvement on both CT and sonography. Using 19F MR, tissue perfusion and tissue pO2 measurements can be achieved. As can be seen, the applications of PFC in diagnosis are vast, unique, and important. These new capabilities will carry radiological tools to new horizons.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087248     DOI: 10.3109/10731199409117422

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  15 in total

Review 1.  Advances in molecular imaging with ultrasound.

Authors:  Ryan Gessner; Paul A Dayton
Journal:  Mol Imaging       Date:  2010-06       Impact factor: 4.488

Review 2.  Blood substitutes: possibilities with nanotechnology.

Authors:  Feroz Alam; Neha Yadav; Murad Ahmad; Mariyam Shadan
Journal:  Indian J Hematol Blood Transfus       Date:  2013-12-10       Impact factor: 0.900

3.  Technical challenges in 3 T magnetic resonance spectroscopic imaging of the prostate-A single-institution experience.

Authors:  Haesun Choi; Michelle Underwood; Piyaporn Boonsirikamchai; Surena Matin; Patricia Troncoso; Jingfei Ma
Journal:  Quant Imaging Med Surg       Date:  2014-08

4.  Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.

Authors:  Paul S Sheeran; Terry O Matsunaga; Paul A Dayton
Journal:  Phys Med Biol       Date:  2013-12-19       Impact factor: 3.609

Review 5.  (19)F MRI for quantitative in vivo cell tracking.

Authors:  Mangala Srinivas; Arend Heerschap; Eric T Ahrens; Carl G Figdor; I Jolanda M de Vries
Journal:  Trends Biotechnol       Date:  2010-04-26       Impact factor: 19.536

6.  Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.

Authors:  Paul S Sheeran; Vincent P Wong; Samantha Luois; Ryan J McFarland; William D Ross; Steven Feingold; Terry O Matsunaga; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2011-07-19       Impact factor: 2.998

7.  Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.

Authors:  Paul S Sheeran; Juan D Rojas; Connor Puett; Jordan Hjelmquist; Christopher B Arena; Paul A Dayton
Journal:  Ultrasound Med Biol       Date:  2015-01-22       Impact factor: 2.998

Review 8.  Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.

Authors:  G M Lanza; P M Winter; S D Caruthers; M S Hughes; Grace Hu; A H Schmieder; S A Wickline
Journal:  Angiogenesis       Date:  2010-04-22       Impact factor: 9.596

Review 9.  Phase-change contrast agents for imaging and therapy.

Authors:  Paul S Sheeran; Paul A Dayton
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 10.  Liquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRI.

Authors:  Raquel Díaz-López; Nicolas Tsapis; Elias Fattal
Journal:  Pharm Res       Date:  2009-11-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.